Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review

The aim of this study was to assess the treatment patterns and safety of sunitinib, sorafenib and bevacizumab in real-world clinical settings in US, Europe and Asia. Medical records were abstracted at 18 community oncology clinics in the US and at 21 tertiary oncology centers in US, Europe and Asia...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: OH, WILLIAM K., McDERMOTT, DAVID, PORTA, CAMILLO, LEVY, ANTONIN, ELAIDI, REZA, SCOTTE, FLORIAN, HAWKINS, ROBERT, CASTELLANO, DANIEL, BELLMUNT, JOAQUIM, RHA, SUN YOUNG, SUN, JONG-MU, NATHAN, PAUL, FEINBERG, BRUCE A., SCOTT, JEFFREY, McDERMOTT, RAY, AHN, JIN-HEE, WAGSTAFF, JOHN, CHANG, YEN-HWA, OU, YEN-CHUAN, DONNELLAN, PAUL, HUANG, CHAO-YUAN, McCAFFREY, JOHN, CHIANG, PO-HUI, CHUANG, CHENG-KENG, KORVES, CAROLINE, NEARY, MAUREEN P., DIAZ, JOSE R., MEHMUD, FAISAL, DUH, MEI SHENG
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2013
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3867384/
https://ncbi.nlm.nih.gov/pubmed/24247547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2013.2181
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky